Duloxetine Hydrochloride Capsule, Delayed Release Pellets
Product Images NDC 50771-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Duloxetine Hydrochloride (NDC 50771-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yaopharma Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (1566564938743)

Structural Formula (1566564938743)
FDA Label Image

20mg (20mg60)

20mg (20mg60)
FDA Label Image

30mg (30mg90)

30mg (30mg90)
FDA Label Image

60mg (60mg30)

60mg (60mg30)
FDA Label Image

90beaf4a 3b90 2d90 E053 2995a90a335e

90beaf4a 3b90 2d90 E053 2995a90a335e
Not available.*
FDA Label Image

90beaf4a 3b91 2d90 E053 2995a90a335e

90beaf4a 3b91 2d90 E053 2995a90a335e
FDA Label Image

90bf2493 E18e 655e E053 2995a90ac94e

90bf2493 E18e 655e E053 2995a90ac94e
FDA Label Image

F1 (F1)

F1 (F1)
The text provides information about the proportion of patients with relapse for two different treatments: placebo and Duloxetine delayed-release capsules. The data is presented in a graph, showing the time from randomization to relapse in days. Unfortunately, specific values or percentages are not readable from the text.*
FDA Label Image

F2 (F2)

F2 (F2)
The text appears to be a graph showing the proportion of patients with relapse over time for two treatments: placebo and duloxetine delayed-release capsules. The graph displays the time from randomization to relapse in days on the x-axis and the proportion of patients on the y-axis. The specific data points on the graph are not legible.*
FDA Label Image

F3 (F3)

F3 (F3)
FDA Label Image

F4 (F4)

F4 (F4)
FDA Label Image

F7 (F7)

F7 (F7)
FDA Label Image

F8 (F8)

F8 (F8)
FDA Label Image

F9 (F9)

F9 (F9)
This text appears to be showing the percentage of patients who have improved, along with some data points related to pain improvement. The data includes percentages of improvement and specific numbers for pain improvement from baseline. However, without more context or legible text, it is difficult to provide a more detailed description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.